Detalles de la búsqueda
1.
Applicability of RPMI 2650 and Calu-3 Cell Models for Evaluation of Nasal Formulations.
Pharmaceutics
; 14(2)2022 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35214101
2.
In Vitro Ciliotoxicity and Cytotoxicity Testing of Repeated Chronic Exposure to Topical Nasal Formulations for Safety Studies.
Pharmaceutics
; 13(11)2021 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34834166
3.
Prediction of pharmacokinetic studies outcome for locally acting nasal sprays by using different in vitro methods.
Int J Pharm
; 601: 120569, 2021 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33812972
4.
Standardization of esophageal adenocarcinoma in vitro model and its applicability for model drug testing.
Sci Rep
; 11(1): 6664, 2021 03 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33758229
5.
Suitability and functional characterization of two Calu-3 cell models for prediction of drug permeability across the airway epithelial barrier.
Int J Pharm
; 585: 119484, 2020 Jul 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-32485216
6.
Biopharmaceutical classification of desloratadine - not all drugs are classified the easy way.
Acta Pharm
; 70(2): 131-144, 2020 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31955139
7.
Suitability of RPMI 2650 cell models for nasal drug permeability prediction.
Eur J Pharm Biopharm
; 145: 85-95, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31639418
8.
Implementation of quality by design principles in the development of microsponges as drug delivery carriers: Identification and optimization of critical factors using multivariate statistical analyses and design of experiments studies.
Int J Pharm
; 489(1-2): 58-72, 2015 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25895722
Resultados
1 -
8
de 8
1
Próxima >
>>